About SeDia

Message from the SeDia Principal Investigator

As the Director of the IMU–Institute for Research, Development, and Innovation (IRDI) and Principal Investigator of the Seremban Diabetes (SeDia) Cohort study, it is my pleasure to welcome you to our website.

Since 2015, the International Medical University (IMU) has been conducting various research studies at the Seremban Health Clinic and at least 70% of the projects were related to diabetes. Now more than ever, there is a rising need for salient and high-quality data, and this has propelled the establishment of SeDia, which aims to develop effective and culturally acceptable intervention protocols that are sustainable and cost-effective to implement.

At SeDia, we are dedicated to studying the determinants of complications in individuals with Type 2 Diabetes Mellitus (T2DM) and examining the roles of genetic, physiological, lifestyle, and psycho-social factors in the development of T2DM. Our aim is to provide high-quality big data related to diabetes for the development of precision medicine/health at the primary care level for diabetic patients and their family members. The project has been approved by IMU Joint Committee for Ethic and Research (IMU-JC) and Medical Research and Ethic Committee (MREC), Ministry of Health Malaysia.

We are positive that the public and SeDia participants will benefit from this website; where they can equip themselves with knowledge and preventative care to curb diabetes.

We welcome researchers and industries to collaborate with us and support our research and development efforts. We believe that working together is key in addressing the national agenda of reducing the burden of diabetes in Malaysia.

We also call upon the generosity of the public, corporate, and philanthropic sectors to support and contribute towards addressing this national agenda. Your contributions will enable us to continue our research and development efforts and make a significant impact on the lives of individuals with diabetes and their families.

In conclusion, we are committed to addressing the issue of diabetes and improving the lives of individuals affected by this chronic illness. We look forward to your support and collaboration towards this important national agenda.

Thank you.
Professor Datuk Dr Lokman Hakim Bin Sulaiman
Deputy Vice-Chancellor, Research, IMU
Director, Institute for Research, Development and Innovation (IRDI)
Principal Investigator, SeDia

SeDia Cohort is established, maintained and governed as a collaborative public-private partnership between the Ministry of Health (MOH), Malaysia and the International Medical University (IMU), Kuala Lumpur. The MOH will be represented by Negeri Sembilan Health Department and Seremban District Health Office.